Rapid expansion in the markets for biologics and small molecule pharmaceutical products has created a critical demand for skilled professionals (from equipment operators to advanced technical and quality assurance personnel) and additional infrastructure to support drug development and manufacturing. The current Good Manufacturing Practice (cGMP) Facility at the University of Rhode Island (URI) offers a state-of-the-art training, development and manufacturing facility for GMP production of solid oral dosage forms. Construction of the Facility is complete, validation is underway and the Facility is “on target” for its scheduled opening in March of 2016.
This facility supports the University’s continuing efforts to strengthen and expand its education, research and development capabilities and allows the limited production of pharmaceutical / biotechnology products for veterinary and human use. The facility’s mission is to:
- Facilitate the development of new pharmaceutics by researchers at URI and their academic and industry partners
- Engage private partners to enhance the economic development of the Rhode Island pharmaceutical and biotechnology industries.
- Develop a world-class teaching and training facility for faculty, students and the biotech/pharmaceutical industry.